119 related articles for article (PubMed ID: 33595778)
1. Analysis of the P
Frankel BM; Cachia D; Patel SJ; Das A
J Mol Neurosci; 2021 Aug; 71(8):1714-1722. PubMed ID: 33595778
[TBL] [Abstract][Full Text] [Related]
2. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
[TBL] [Abstract][Full Text] [Related]
6. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
7. Analysis of P
Frankel BM; Cachia D; Patel SJ; Das A
J Mol Neurosci; 2020 Sep; 70(9):1415-1424. PubMed ID: 32367506
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
[TBL] [Abstract][Full Text] [Related]
9. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
Suarez-Merino B; Hubank M; Revesz T; Harkness W; Hayward R; Thompson D; Darling JL; Thomas DG; Warr TJ
Neuro Oncol; 2005 Jan; 7(1):20-31. PubMed ID: 15701279
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma.
Weremowicz S; Kupsky WJ; Morton CC; Fletcher JA
Cancer Genet Cytogenet; 1992 Jul; 61(2):193-6. PubMed ID: 1638502
[TBL] [Abstract][Full Text] [Related]
13. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
[TBL] [Abstract][Full Text] [Related]
14. p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas.
Loiseau H; Arsaut J; Demotes-Mainard J
Neurosci Lett; 1999 Mar; 263(2-3):173-6. PubMed ID: 10213163
[TBL] [Abstract][Full Text] [Related]
15. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
17. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
18. Constitutional de novo t(1;22)(p22;q11.2) and ependymoma.
Park JP; Chaffee S; Noll WW; Rhodes CH
Cancer Genet Cytogenet; 1996 Feb; 86(2):150-2. PubMed ID: 8603343
[TBL] [Abstract][Full Text] [Related]
19. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
